Masatoshi Shirane

679 total citations
23 papers, 561 citations indexed

About

Masatoshi Shirane is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Masatoshi Shirane has authored 23 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Masatoshi Shirane's work include Neuroscience and Neuropharmacology Research (4 papers), Breast Cancer Treatment Studies (4 papers) and Gene expression and cancer classification (3 papers). Masatoshi Shirane is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Breast Cancer Treatment Studies (4 papers) and Gene expression and cancer classification (3 papers). Masatoshi Shirane collaborates with scholars based in Japan, United States and France. Masatoshi Shirane's co-authors include Kazuo Nakamura, Kazushige Mori, Yoshihiro Kazama, Tomomichi Kiyomatsu, Hirokazu Nagawa, Junichiro Tanaka, Takamitsu Kanazawa, Toshiaki Watanabe, Toshiaki Tanaka and Tetsuichiro Muto and has published in prestigious journals such as Development, Cancer Research and Brain Research.

In The Last Decade

Masatoshi Shirane

23 papers receiving 539 citations

Peers

Countries citing papers authored by Masatoshi Shirane

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Shirane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Shirane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Shirane more than expected).

Fields of papers citing papers by Masatoshi Shirane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Shirane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Shirane. The network helps show where Masatoshi Shirane may publish in the future.

Co-authorship network of co-authors of Masatoshi Shirane

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Shirane. A scholar is included among the top collaborators of Masatoshi Shirane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Shirane. Masatoshi Shirane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systemic administrations of protamine heal subacute spinal cord injury in mice. 2024 ·Neuroscience Research ·Tomoya Ozaki, Toshiharu Sugie, Yuji Suzuki, Kenji Uchimura, (unknown), Kazuma Sakamoto, Masatoshi Shirane, Kenji Kadomatsu	1
2	Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer 2012 ·Cancer Science ·Naoki Niikura, Takayuki Iwamoto, Shinobu Masuda, Nobue Kumaki, Xiaoyan Tang, Masatoshi Shirane, Kazushige Mori, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda	39
3	Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts 2011 ·Oncology Reports ·Toshiki Iwai, Yoichiro Moriya, Masatoshi Shirane, Kaori Fujimoto-Ouchi, Kazushige Mori	12
4	High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers 2010 ·Oncology Letters ·Shinobu Umemura, Masatoshi Shirane, Susumu Takekoshi, Yutaka Tokuda, Kazushige Mori, R. Yoshiyuki Osamura	5
5	[Microarray analysis of tumor xenograft model]. 2010 ·PubMed ·(unknown), Masatoshi Shirane, Kazushige Mori, (unknown), Masahide Fujita	1
6	Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy 2009 ·Cancer Chemotherapy and Pharmacology ·Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Kaname Yamamoto, Masatoshi Shirane, Yoriko Yamashita, Kazushige Mori	18
7	Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome 2009 ·British Journal of Cancer ·(unknown), Masatoshi Shirane, Susumu Takekoshi, Takahiko Kusakabe, (unknown), Noboru Egashira, Yutaka Tokuda, Kazushige Mori, Yoshiyuki Osamura	44
8	Chemosensitivity-related genes of breast cancer detected by DNA microarray. 2007 ·PubMed ·Tadashi Ikeda, Hiromitsu Jinno, Masatoshi Shirane	5
9	Prediction of Sensitivity of Rectal Cancer Cells in Response to Preoperative Radiotherapy by DNA Microarray Analysis of Gene Expression Profiles 2006 ·Cancer Research ·Toshiaki Watanabe, Yasuhiro Komuro, Tomomichi Kiyomatsu, Takamitsu Kanazawa, Yoshihiro Kazama, Junichiro Tanaka, Toshiaki Tanaka, Yoko Yamamoto, Masatoshi Shirane, Tetsuichiro Muto, Hirokazu Nagawa	184
10	Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models 2006 ·Cancer Chemotherapy and Pharmacology ·Kaori Fujimoto-Ouchi, Etsuro Onuma, Masatoshi Shirane, Kazushige Mori, Yutaka Tanaka	14
11	Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis 2005 ·British Journal of Cancer ·Masanori Terashima, Chihaya Maesawa, Keisuke Oyama, S. Ohtani, Yuji Akiyama, Satoshi Ogasawara, Akinori Takagane, Kazuyoshi Saito, Takahiro Masuda, (unknown), S Matsuyama, Yutaka Hoshino, (unknown), Mari Gotoh, Masatoshi Shirane, Koichiro Mori	46
12	Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma. 2005 ·PubMed ·Kenji Hibi, Yasuhiro Kodera, Katsuki Ito, Seiji Akiyama, Masatoshi Shirane, Akimasa Nakao	8
13	Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy 2004 ·International Journal of Oncology ·Yasuhiro Inoue, Masatoshi Shirane, Chikao Miki, Junichiro Hiro, Koji Tanaka, Minàko Kobayashi, Kazushige Mori, Hidenori Yanagi, Masato Kusunoki	9
14	Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP 2001 ·Brain Research ·Masatoshi Shirane, Kazuo Nakamura	27
15	Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats 2001 ·Brain Research ·Kazuo Nakamura, Masatoshi Shirane, Noriaki Koshikawa	25
16	Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP 2000 ·Neuropharmacology ·Masatoshi Shirane, Kazuo Nakamura	16
17	Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats 2000 ·Brain Research ·Kazuo Nakamura, Mitsue Kurasawa, Masatoshi Shirane	21
18	Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam 1999 ·European Journal of Pharmacology ·Kazuo Nakamura, Masatoshi Shirane	25
19	Possible Mechanisms of Action of the Antispasmodic Agent Tiropramide in the Isolated Detrusor from Rats. 1992 ·The Japanese Journal of Pharmacology ·Tsutomu Uruno, Masatoshi Shirane, Koh‐ichi Wada, (unknown), (unknown), Yutaka Matsuoka, (unknown), (unknown)	4
20	Possible Mechanisms of Action of the Antispasmodic Agent Tiropramide in the Isolated Detrusor from Rats 1992 ·The Japanese Journal of Pharmacology ·Tsutomu Uruno, Masatoshi Shirane, (unknown), (unknown), (unknown), (unknown), (unknown), Kazuhiko Kubota	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact